Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F0WM8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,604
Award facts
- Contract value 100% obligated
- $79,603.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $79,603.54 to AmerisourceBergen Drug Corp for 300 milligram/2 milliliter Dupixent pens on November 10, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a specialty biologic medication used to treat multiple inflammatory conditions, and this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceuticals and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains extensive federal contracting relationships with the Defense Logistics Agency and serves critical medical supply needs for military and veteran healthcare systems. As the prime contractor on the DLA Troop Support Medical IDC vehicle, the company provides a broad portfolio of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order represents a routine transaction within AmerisourceBergen's established framework for supplying specialty medications to federal customers.
Quick answers
Who was awarded contract SPE2DR26F0WM8?
SPE2DR26F0WM8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26F0WM8 worth?
The government has obligated $79,604 on SPE2DR26F0WM8.
Is contract SPE2DR26F0WM8 an order under another contract?
Yes. SPE2DR26F0WM8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0WM8 competed?
The extent of competition for SPE2DR26F0WM8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award